STTKShattuck Labs, Inc.

$291M

Q4 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$714,000+83.1% YoY

Gross Profit

-$267,000-37.4% margin

Operating Income

-$19M-2654.2% margin

Net Income

-$18M-2477.2% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+4.1%

Cash Flow

Operating Cash Flow

-$19M

Free Cash Flow

-$19M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$160M

Total Liabilities

$15M

Stockholders' Equity

$145M

Cash & Equivalents

$126M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$714,000	$390,000	+83.1%
Gross Profit	-$267,000	-$21M	+98.7%
Operating Income	-$19M	-$26M	+27.9%
Net Income	-$18M	-$25M	+30.4%

STTK Q4 2023 Earnings — Shattuck Labs, Inc. Revenue & Financial Results | Market Cap Arena